BIOSTATUS LTD

Unknown (Unknown)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£74,647

Jun 20 - Feb 21

Novel Cellular Probe Technologies for Screening Anti-Viral Therapeutic Candidates on Multiple Platforms

Innovate UK award to BIOSTATUS LTD and Stefan Ogrodzinski

£21,000

Jan 17 - Mar 17

Exploiting Tumour Hypoxia in Precision Medicine: Advancing Novel Prodrug Therapies for Pancreatic Cancer with a World-leading Canadian Cancer Centre

Innovate UK award to ONCOTHERICS LIMITED and Stefan Ogrodzinski

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}